Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2439-85-2 | MDL No. : | MFCD00005888 |
Formula : | C8H4BrNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MARXMDRWROUXMD-UHFFFAOYSA-N |
M.W : | 226.03 | Pubchem ID : | 75542 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 49.78 |
TPSA : | 37.38 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.48 cm/s |
Log Po/w (iLOGP) : | 1.6 |
Log Po/w (XLOGP3) : | 1.69 |
Log Po/w (WLOGP) : | 1.21 |
Log Po/w (MLOGP) : | 1.72 |
Log Po/w (SILICOS-IT) : | 1.62 |
Consensus Log Po/w : | 1.57 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.68 |
Solubility : | 0.477 mg/ml ; 0.00211 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.09 |
Solubility : | 1.84 mg/ml ; 0.00813 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.92 |
Solubility : | 0.27 mg/ml ; 0.0012 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.39 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362+P364-P403+P233-P501 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90.8% | With glycolic Acid; N-(tert-butoxy)-1H-pyrrole-2-carboxamide; toluene-4-sulfonic acid In 1,4-dioxane; acetonitrile at 80℃; for 10 h; | At room temperature,100 mmol of the compound of formula (I)100 mmol of the compound of formula (II)16 mmol of catalyst (mixture of 8 mmol of ruthenium tetracarbonyl diboride and 8 mmol of triphenylphosphine copper (Cu (PPh3) Br)140 mmol of acetoxyacetyl chloride,30 mmol of acidic compound p-toluenesulfonic acid and 6 mmol of additive L were added to an appropriate organic solvent (volume ratio 2: 1Of a mixture of acetonitrile and 1,4-dioxane)Then heated to 80 ° C,And the reaction was stirred at that temperature for 10 hours;After the reaction,The reaction system was filtered,And with the alkali to adjust the pH value of the filtrate is neutral,Then vacuum distillation,The residue was passed through a silica gel column,In an equal volume of a mixture of chloroform and ethyl acetate,And again under reduced pressure distillation,To give a compound of the above formula (III) having a melting point of 109 to 110 ° C (wherein Ac is acetoxy, the same applies hereinafter) in a yield of 90.8percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80.6% | With di(rhodium)tetracarbonyl dichloride; triphenylphosphine copper; toluene-4-sulfonic acid In 1,4-dioxane; acetonitrile at 100℃; for 8 h; | At room temperature, 100 mmol of the compound of formula (I)150 mmol of the compound of formula (II)14 mmol of a catalyst (a mixture of 7 mmol of ruthenium tetracarbonyl diboride and 7 mmol of triphenylphosphine copper (Cu (PPh3) Br)160 mmol of acetoxyacetyl chloride and 25 mmol of acidic compound p-toluenesulfonic acid were added to an appropriate organic solvent (a mixture of acetonitrile and 1,4-dioxane in a volume ratio of 2: 1) and then heated to 100 ° C The reaction was stirred at this temperature for 8 hours;After completion of the reaction, the reaction system was filtered and the pH of the filtrate was adjusted to pH with a base, and then distilled under reduced pressure The silica gel column was eluted with an equal volume of a mixture of chloroform and ethyl acetate and distilled again under reduced pressure to give The compound of the above formula (III) having a melting point of 109 to 110 ° C has a yield of 80.6percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | at 100℃; for 0.166667 h; Microwave irradiation | Example 1: Synthesis of 2-(Cyclohexylthio)isoindoline-l,3-dione.; The following compound was used as an intermediate product in the synthesis of sulfenyl guanidine prodrugs of metformin.Dicyclohexyl disulphide (0.51 g, 2.21 mmol) and iV-bromophthalimide (0.50 g, 2.21 mmol) in anhydrous ACN (20 ml) were irradiated at 100 0C (1 bar) in a microwave reactor for 10 min. The solvent was evaporated under reduced pressure and the residue was purified by flash chromatography eluting with hexane/ethyl acetate (2:1) solution to obtain the compound 1 as a light yellow solid (0.29 g, 52percent).1H NMR (CDCl3): δ 7.95-7.91 (2H, dd, 3JHH = 5.46 Hz, 4JHH = 3.07 Hz), 7.81-7.76 (2H, dd, 3JHH = 5.46 Hz, 4JHH = 3.07 Hz), 3.22-3.15 (IH, tt, 3JHH = 3.63, 10.88 Hz), 1.95-1.88 (2H, m), 1.84-1.75 (2H, m), 1.65-1.57 (IH, m), 1.43-1.33 (2H, m), 1.32-1.18 (3H, m). |